Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For WEX
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 1.44 1.06 1.05
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 18.27 8.70 7.35
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.19 42.53 43.04
Cash 3.79 128.87 124.16
Capex 17.88 -0.81 -0.99
Free Cash Flow -73.82 -4.48 17.12
Revenue -0.42 15.61 15.68
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -1.81 0.55 0.56
Operating Margin 5.47 0.25 0.24
ROA -25.40 < 0.005 < 0.005
ROE -20.63 0.04 0.05
ROIC -7.51 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of WEX is permitted for members.
5 Growth
The "Growth Entry" for the Focus of WEX is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of WEX is permitted for members.